Core Points - MediPharm Labs Corp. will release its third quarter financial results for the three and nine months ended September 30, 2025, before markets open on November 13, 2025 [1] - The executive management team will host a conference call and webcast on the same day at 10:00 a.m. Eastern time to discuss the financial results [2] Company Overview - MediPharm Labs, founded in 2015, specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates and advanced derivative products [5] - The company operates a Good Manufacturing Practices certified facility with ISO standard-built clean rooms, focusing on delivering pure and precision-dosed cannabis products [5] - In 2021, MediPharm received a Pharmaceutical Drug Establishment License from Health Canada, becoming the only company in North America with a commercial-scale domestic GMP License for the extraction of multiple natural cannabinoids [6] - In 2023, MediPharm acquired VIVO Cannabis Inc., expanding its reach to medical patients in Canada, Australia, and Germany [7]
MediPharm Labs Sets Date to Report Third Quarter 2025 Financial Results
Globenewswire·2025-11-10 23:00